P.02.3 CLINICAL BENEFITS OF GLUTEN FREE DIET IN PARKINSON'S DISEASE. A CASE REPORT

2014 ◽  
Vol 46 ◽  
pp. S56-S57
Author(s):  
G. Iafrancesco ◽  
R. Filippetti
2021 ◽  
Vol 14 (1) ◽  
pp. 18-21
Author(s):  
Sanju George ◽  
Jacob Chacko ◽  
Sheetal Cyriac

Parkinson’s disease is primarily a neurodegenerative disorder and presents with neurological symptoms but it can also have  accompanying psychiatric symptoms. In addition, in some patients with Parkinson’s disease there can be an awakening of their creativity, which can take several forms. Such creativity can be seen in art-naïve patients or in whom the creativity lay dormant. Although the precise mechanism for this phenomenon is not understood, treatment with levodopa and dopamine agonists have been considered responsible in some cases. Here, we describe a patient with Parkinson’s disease in whom levodopa treatment triggered a latent creative skill that was dormant since childhood. Through the patient’s own and his wife’s eyes, we discuss the clinical benefits of this phenomenon.


2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Alexandre Boutet ◽  
Radhika Madhavan ◽  
Gavin J. B. Elias ◽  
Suresh E. Joel ◽  
Robert Gramer ◽  
...  

AbstractCommonly used for Parkinson’s disease (PD), deep brain stimulation (DBS) produces marked clinical benefits when optimized. However, assessing the large number of possible stimulation settings (i.e., programming) requires numerous clinic visits. Here, we examine whether functional magnetic resonance imaging (fMRI) can be used to predict optimal stimulation settings for individual patients. We analyze 3 T fMRI data prospectively acquired as part of an observational trial in 67 PD patients using optimal and non-optimal stimulation settings. Clinically optimal stimulation produces a characteristic fMRI brain response pattern marked by preferential engagement of the motor circuit. Then, we build a machine learning model predicting optimal vs. non-optimal settings using the fMRI patterns of 39 PD patients with a priori clinically optimized DBS (88% accuracy). The model predicts optimal stimulation settings in unseen datasets: a priori clinically optimized and stimulation-naïve PD patients. We propose that fMRI brain responses to DBS stimulation in PD patients could represent an objective biomarker of clinical response. Upon further validation with additional studies, these findings may open the door to functional imaging-assisted DBS programming.


1993 ◽  
Vol 44 (3) ◽  
pp. 225-230
Author(s):  
Ken Ito ◽  
Tetsuo Semba ◽  
Yasushi Ohta ◽  
Tadashi Tanaka

Sign in / Sign up

Export Citation Format

Share Document